Vaccines for preventing herpes zoster in older adults.

CONCLUSIONS: Herpes zoster vaccine is effective in preventing herpes zoster disease. Although vaccine benefits are larger in the younger age group (60 to 69 years), this is also the age group with more adverse events. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse effects of mild to moderate intensity. PMID: 25055074 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25055074?dopt=Abstract

Source: Sao Paulo Medical Journal - July 24, 2014 Category: Journals (General) Authors: Gagliardi AM, Silva BN, Torloni MR, Soares BG Tags: Sao Paulo Med J Source Type: research